Noticias Petros Pharmaceuticals - PTPI

Nombre de la Acción	Símbolo de la Acción	Bolsa de Valores	Tipo de Valor
Petros Pharmaceuticals Inc	PTPI	NASDAQ	Acción Común

	Variación del Día (ptos.)	Variación del Día (%)	Último Precio	Hora
	-0.0219	-3.37%	0.6284	14:13:48

Precio de Apertura	Precio Mínimo	Precio Máximo	Precio de cierre	Precio Anterior
0.6503	0.6116	0.6798		0.6503

Noticias Recientes

Fecha	Hora	Fuente	Noticia
20/5/2024	23:15	EDGAR2	Form EFFECT - Notice of Effectiveness
14/5/2024	06:00	GLOBE	Lemonaid Health Now Offers Prescription ED Medication..
12/1/2024	15:32	EDGAR2	Form 8-K - Current report
29/12/2023	15:05	EDGAR2	Form 8-K - Current report
28/12/2023	15:05	EDGAR2	Form 8-K - Current report
26/12/2023	16:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
26/12/2023	16:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
26/12/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
30/11/2023	15:05	EDGAR2	Form DEF 14A - Other definitive proxy statements
15/11/2023	16:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/2023	16:00	EDGAR2	Form NT 10-Q - Notification of inability to timely file Form..
02/10/2023	07:00	EDGAR2	Form 8-K - Current report
19/9/2023	15:36	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
15/9/2023	16:16	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
15/9/2023	15:22	EDGAR2	Form 8-K - Current report
25/8/2023	16:08	EDGAR2	Form DEF 14A - Other definitive proxy statements
15/8/2023	16:03	EDGAR2	Form 8-K - Current report
15/8/2023	16:01	EDGAR2	Form PRE 14A - Other preliminary proxy statements
14/8/2023	16:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/2023	15:31	EDGAR2	Form S-3 - Registration statement under Securities Act of..
13/7/2023	15:41	EDGAR2	Form 8-K - Current report